Interaction between Neuromelanin and Alpha-Synuclein in Parkinson's Disease

Parkinson's disease (PD) is a very common neurodegenerative disorder characterized by the accumulation of α-synuclein (α-syn) into Lewy body (LB) inclusions and the loss of neuronmelanin (NM) containing dopamine (DA) neurons in the substantia nigra (SN). Pathological α-syn and NM are two promin...

Full description

Saved in:
Bibliographic Details
Published inBiomolecules (Basel, Switzerland) Vol. 5; no. 2; pp. 1122 - 1142
Main Authors Xu, Shengli, Chan, Piu
Format Journal Article Book Review
LanguageEnglish
Published Switzerland MDPI AG 05.06.2015
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Parkinson's disease (PD) is a very common neurodegenerative disorder characterized by the accumulation of α-synuclein (α-syn) into Lewy body (LB) inclusions and the loss of neuronmelanin (NM) containing dopamine (DA) neurons in the substantia nigra (SN). Pathological α-syn and NM are two prominent hallmarks in this selective and progressive neurodegenerative disease. Pathological α-syn can induce dopaminergic neuron death by various mechanisms, such as inducing oxidative stress and inhibiting protein degradation systems. Therefore, to explore the factors that trigger α-syn to convert from a non-toxic protein to toxic one is a pivotal question to clarify the mechanisms of PD pathogenesis. Many triggers for pathological α-syn aggregation have been identified, including missense mutations in the α-syn gene, higher concentration, and posttranslational modifications of α-Syn. Recently, the role of NM in inducing α-syn expression and aggregation has been suggested as a mechanism for this pigment to modulate neuronal vulnerability in PD. NM may be responsible for PD and age-associated increase and aggregation in α-syn. Here, we reviewed our previous study and other recent findings in the area of interaction between NM and α-syn.
AbstractList Parkinson's disease (PD) is a very common neurodegenerative disorder characterized by the accumulation of α-synuclein (α-syn) into Lewy body (LB) inclusions and the loss of neuronmelanin (NM) containing dopamine (DA) neurons in the substantia nigra (SN). Pathological α-syn and NM are two prominent hallmarks in this selective and progressive neurodegenerative disease. Pathological α-syn can induce dopaminergic neuron death by various mechanisms, such as inducing oxidative stress and inhibiting protein degradation systems. Therefore, to explore the factors that trigger α-syn to convert from a non-toxic protein to toxic one is a pivotal question to clarify the mechanisms of PD pathogenesis. Many triggers for pathological α-syn aggregation have been identified, including missense mutations in the α-syn gene, higher concentration, and posttranslational modifications of α-Syn. Recently, the role of NM in inducing α-syn expression and aggregation has been suggested as a mechanism for this pigment to modulate neuronal vulnerability in PD. NM may be responsible for PD and age-associated increase and aggregation in α-syn. Here, we reviewed our previous study and other recent findings in the area of interaction between NM and α-syn.
Author Chan, Piu
Xu, Shengli
AuthorAffiliation 2 Parkinson’s disease Center of Beijing Institute for Brain Disorders, Beijing 100053, China
1 Beijing Institute of Geriatrics, Xuanwu Hospital of Capital University of Medical Sciences, No.45 changchun St., Xicheng District, Beijing 100053, China; E-Mail: xushngli_xw@163.com
AuthorAffiliation_xml – name: 1 Beijing Institute of Geriatrics, Xuanwu Hospital of Capital University of Medical Sciences, No.45 changchun St., Xicheng District, Beijing 100053, China; E-Mail: xushngli_xw@163.com
– name: 2 Parkinson’s disease Center of Beijing Institute for Brain Disorders, Beijing 100053, China
Author_xml – sequence: 1
  givenname: Shengli
  surname: Xu
  fullname: Xu, Shengli
  email: xushngli_xw@163.com, xushngli_xw@163.com
  organization: Parkinson's disease Center of Beijing Institute for Brain Disorders, Beijing 100053, China. xushngli_xw@163.com
– sequence: 2
  givenname: Piu
  surname: Chan
  fullname: Chan, Piu
  email: pbchan90@gmail.com, pbchan90@gmail.com
  organization: Parkinson's disease Center of Beijing Institute for Brain Disorders, Beijing 100053, China. pbchan90@gmail.com
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26057626$$D View this record in MEDLINE/PubMed
BookMark eNpdkd1LHDEUxUOxVGt96nsZ8MGCTJuPSTZ5EcS2ulRsQQt9C5nkjmadSdZkpsX_vlnXymq4kHBz-OXknrdoK8QACL0n-BNjCn9ufRw4poRQ-grtUEpkTWfs99bGeRvt5bzAZclSlL1B21RgPhNU7KDv8zBCMnb0MVQtjH8BQnUBU4oD9Cb4UJngquN-eWPqy_sw2R5Kr9RPk259yDEc5OqLz2AyvEOvO9Nn2Hvcd9Gvb1-vTs7q8x-n85Pj89o2Mz7WTjJgzihsoWmUbC21higumBEEN44qZyQ45pqOd6WHmXNEdZiJljonlWO7aL7mumgWepn8YNK9jsbrh0ZM19qk0RerGgyXLQhWvqsaSZzCLePAubO8weWFwjpas5ZTO4CzEMZk-mfQ5zfB3-jr-EcX62JGWAF8fASkeDdBHvXgs4W-DA_ilDURigiMVUOKdP-FdBGnFMqoViqBC02ugIdrlU0x5wTdkxmC9SpzvZF5UX_Y9P-k_Z8w-weF-KlT
CitedBy_id crossref_primary_10_1007_s00702_023_02673_y
crossref_primary_10_1111_cns_13916
crossref_primary_10_1515_revneuro_2018_0105
crossref_primary_10_3390_nutraceuticals3010004
crossref_primary_10_3390_metabo7020022
crossref_primary_10_1007_s12640_017_9804_z
crossref_primary_10_4081_ejh_2021_3283
crossref_primary_10_1007_s00203_021_02437_w
crossref_primary_10_1007_s00702_020_02150_w
crossref_primary_10_3389_fnagi_2020_00060
crossref_primary_10_1073_pnas_2109617119
crossref_primary_10_1371_journal_pone_0145493
crossref_primary_10_1523_JNEUROSCI_1079_16_2016
crossref_primary_10_1007_s00204_016_1757_0
crossref_primary_10_3390_ani12131633
crossref_primary_10_1016_j_biopha_2017_03_100
crossref_primary_10_3233_RNN_180817
crossref_primary_10_1016_j_arr_2020_101152
crossref_primary_10_3390_cells8060592
crossref_primary_10_1007_s00702_019_02025_9
crossref_primary_10_1016_j_bbi_2020_07_044
crossref_primary_10_3390_ijms23084176
crossref_primary_10_1111_pcmr_12709
crossref_primary_10_1002_1873_3468_14361
crossref_primary_10_1002_ana_24802
crossref_primary_10_3389_fnagi_2018_00134
crossref_primary_10_1111_nan_12299
Cites_doi 10.1016/j.neuron.2009.01.033
10.1038/42166
10.1007/s00702-006-0453-2
10.1523/JNEUROSCI.1560-11.2011
10.1126/science.1077209
10.1016/0028-3908(86)90242-X
10.1385/MN:31:1-3:243
10.1046/j.1471-4159.1994.62010369.x
10.1186/gb-2001-3-1-reviews3002
10.1007/s00702-005-0410-5
10.1371/journal.pone.0045183
10.1002/ana.410430320
10.1073/pnas.0406283101
10.1371/journal.pone.0010481
10.1111/j.1600-0749.1987.tb00403.x
10.1126/science.1129462
10.1046/j.1471-4159.2003.01923.x
10.1097/00005072-196907000-00005
10.1007/978-3-7091-0643-3_8
10.1074/jbc.M205518200
10.1007/s00702-013-0966-4
10.1016/j.neulet.2009.02.056
10.1016/j.bbapap.2013.03.008
10.1074/jbc.274.41.28849
10.1016/j.molmed.2011.05.003
10.1016/j.neuron.2004.11.005
10.1073/pnas.1309991110
10.1046/j.1471-4159.1994.62031097.x
10.1074/jbc.M709014200
10.1016/j.neurobiolaging.2014.03.024
10.1021/cn300034t
10.1002/mds.870120607
10.1002/ana.410320712
10.1038/nrn983
10.1002/cne.20098
10.1016/S0896-6273(00)80886-7
10.3233/JPD-130175
10.1021/bi972776r
10.1016/j.baga.2011.01.007
10.1097/NEN.0b013e3186fc995
10.1016/j.febslet.2006.03.018
10.1111/j.1471-4159.1991.tb06358.x
10.1126/science.1090278
10.1126/science.1063522
10.1186/s40478-014-0132-8
10.1074/jbc.M213217200
10.1097/00005072-196507000-00003
10.1074/jbc.M710560200
10.1007/BF02263482
10.1074/jbc.M110.213538
10.1371/journal.pone.0027959
10.1016/S0006-2952(03)00293-4
10.1074/jbc.M208192200
10.1074/jbc.M409946200
10.1016/S0306-4522(03)00036-8
10.1126/science.1096284
10.1007/s00702-004-0211-2
10.1021/bi0102398
10.1074/jbc.M000206200
10.1016/j.arr.2014.01.004
10.1016/j.nbd.2014.05.009
10.1523/JNEUROSCI.22-20-08797.2002
10.1016/j.neurobiolaging.2005.02.015
10.3389/fnmol.2014.00042
10.1073/pnas.97.22.11869
10.1016/0925-4439(95)00058-C
10.1091/mbc.E09-09-0801
10.1097/NEN.0b013e3181a24b53
10.1074/jbc.M109.081950
10.1038/nature10324
10.1101/gr.8.9.871
10.2174/18715273113126660195
10.1371/journal.pone.0070872
10.1111/jnc.12175
10.1016/S0197-0186(02)00161-4
10.1046/j.1471-4159.2003.01917.x
10.1602/neurorx.1.1.139
10.1073/pnas.0710685105
10.1126/science.3080808
10.1007/s12640-009-9140-z
10.1016/S0306-4522(00)00077-4
10.1074/jbc.M600933200
10.1007/s12035-013-8586-4
10.1007/978-1-61779-163-5_30
10.1111/jnc.12806
10.1046/j.1471-4159.2000.740721.x
10.1007/BF03033277
10.1074/jbc.274.14.9843
10.1523/JNEUROSCI.08-08-02804.1988
10.1016/j.neuron.2013.09.004
10.1016/S1353-8020(03)00016-6
10.1111/j.1600-0749.1998.tb00721.x
10.1007/s00702-003-0080-0
10.1074/jbc.M112.439497
10.1073/pnas.1315654110
10.1086/424492
10.1111/j.1600-0749.1994.tb00061.x
10.1016/j.neulet.2004.05.118
10.1007/s12640-013-9435-y
10.1146/annurev.neuro.22.1.123
10.1016/j.pneurobio.2013.04.004
10.1016/j.bbrc.2006.01.148
10.1016/j.brainres.2013.01.024
10.1021/bi5010365
10.1038/ng.485
10.1111/j.1600-0749.2004.00201.x
10.1074/jbc.M300227200
10.1016/0925-4439(92)90144-C
10.1523/JNEUROSCI.20-09-03214.2000
10.1111/j.1471-4159.2008.05385.x
10.1111/j.1749-6632.2000.tb06903.x
10.1074/jbc.M114.553297
10.1016/j.nbd.2005.08.018
10.1093/brain/awh584
10.1074/jbc.M710012200
10.1371/journal.pone.0016706
10.1074/jbc.273.41.26292
10.1523/JNEUROSCI.4308-05.2006
10.1021/bi0341152
10.1038/ncb748
10.1016/S0891-5849(02)00741-4
10.1111/j.1440-1789.2007.00803.x
10.1016/j.neulet.2010.09.061
10.1523/JNEUROSCI.20-17-06365.2000
10.1016/S0002-9440(10)64553-1
10.1111/pcmr.12014
10.1007/s12035-014-8738-1
10.1038/ng.642
10.1155/2012/920953
10.5607/en.2014.23.4.324
10.1046/j.1471-4159.2000.0741758.x
10.1523/JNEUROSCI.0519-06.2006
10.1016/j.nbd.2006.08.021
10.1007/s00401-013-1096-7
10.1371/journal.pone.0026159
10.1073/pnas.1113260108
10.1016/S0892-0362(02)00218-0
10.1016/S0140-6736(04)17103-1
10.1111/j.1742-4658.2011.08093.x
10.1016/j.parkreldis.2006.12.014
10.1002/mds.25095
10.1523/JNEUROSCI.4965-05.2006
10.1212/WNL.18.8.817
10.1016/0304-3940(88)90002-X
10.1523/JNEUROSCI.0297-11.2011
10.1523/JNEUROSCI.3821-06.2006
10.1126/science.276.5321.2045
10.1212/WNL.0b013e31828727ba
10.1016/j.tins.2007.03.009
10.1002/ana.10795
10.1096/fj.02-0314fje
10.1007/s00702-011-0636-3
10.1515/revneuro-2012-0071
10.1046/j.1471-4159.1997.69041720.x
ContentType Journal Article
Book Review
Copyright Copyright MDPI AG 2015
2015 by the authors; licensee MDPI, Basel, Switzerland. 2015
Copyright_xml – notice: Copyright MDPI AG 2015
– notice: 2015 by the authors; licensee MDPI, Basel, Switzerland. 2015
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7T5
7TM
7TO
7X7
7XB
88E
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M7P
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.3390/biom5021122
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Immunology Abstracts
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Biological Science Database
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest Central Essentials
Nucleic Acids Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
AIDS and Cancer Research Abstracts
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database
MEDLINE


MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: AUTh Library subscriptions: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 2218-273X
EndPage 1142
ExternalDocumentID oai_doaj_org_article_ea58be630579481d90b35e55dc540d4f
3742402121
10_3390_biom5021122
26057626
Genre Research Support, Non-U.S. Gov't
Journal Article
Review
GroupedDBID 3V.
53G
5VS
7X7
88E
8FE
8FH
8FI
8FJ
AADQD
AAFWJ
ABDBF
ABUWG
ADBBV
ADRAZ
AFKRA
AFPKN
AFZYC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
CGR
CUY
CVF
EBD
ECM
EIF
ESX
FYUFA
GROUPED_DOAJ
HCIFZ
HMCUK
HYE
IPNFZ
KQ8
LK8
M1P
M48
M7P
MODMG
M~E
NPM
OK1
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
RIG
RPM
UKHRP
AAYXX
CITATION
7T5
7TM
7TO
7XB
8FK
AZQEC
DWQXO
GNUQQ
H94
K9.
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c475t-d83e3da90ce4498bc2ca19563a6104d29da8ed3d4f5f3a603dd19f036b2dd89d3
IEDL.DBID RPM
ISSN 2218-273X
IngestDate Tue Oct 22 15:15:48 EDT 2024
Tue Sep 17 20:42:27 EDT 2024
Sat Aug 17 00:57:12 EDT 2024
Tue Nov 19 06:34:53 EST 2024
Fri Dec 06 00:58:54 EST 2024
Sat Sep 28 07:56:22 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords alpha-synuclein
Parkinson’s disease
oxidative stress
neuromelanin
Language English
License https://creativecommons.org/licenses/by/4.0
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c475t-d83e3da90ce4498bc2ca19563a6104d29da8ed3d4f5f3a603dd19f036b2dd89d3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496713/
PMID 26057626
PQID 1696013383
PQPubID 2032425
PageCount 21
ParticipantIDs doaj_primary_oai_doaj_org_article_ea58be630579481d90b35e55dc540d4f
pubmedcentral_primary_oai_pubmedcentral_nih_gov_4496713
proquest_miscellaneous_1691600941
proquest_journals_1696013383
crossref_primary_10_3390_biom5021122
pubmed_primary_26057626
PublicationCentury 2000
PublicationDate 2015-06-05
PublicationDateYYYYMMDD 2015-06-05
PublicationDate_xml – month: 06
  year: 2015
  text: 2015-06-05
  day: 05
PublicationDecade 2010
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Biomolecules (Basel, Switzerland)
PublicationTitleAlternate Biomolecules
PublicationYear 2015
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References 20852670 - Clin Interv Aging. 2010;5:229-38
23507046 - Biochim Biophys Acta. 2013 Jun;1834(6):972-6
15067721 - J Comp Neurol. 2004 May 17;473(1):97-106
21841800 - Nature. 2011 Sep 1;477(7362):107-10
12388586 - J Neurosci. 2002 Oct 15;22(20):8797-807
10799759 - Neuroscience. 2000;97(2):279-84
21489994 - J Biol Chem. 2011 Jun 10;286(23):20710-26
9326301 - J Neurochem. 1997 Oct;69(4):1720-8
23337620 - Brain Res. 2013 Mar 15;1500:19-27
18162536 - Proc Natl Acad Sci U S A. 2008 Jan 8;105(1):145-50
24277523 - Mol Neurobiol. 2014 Jun;49(3):1153-65
23404372 - Acta Neuropathol. 2013 May;125(5):753-69
10777786 - J Neurosci. 2000 May 1;20(9):3214-20
3334086 - Pigment Cell Res. 1987;1(3):133-6
15615715 - J Biol Chem. 2005 Mar 11;280(10):9678-90
24050397 - Neuron. 2013 Sep 18;79(6):1044-66
18245082 - J Biol Chem. 2008 Apr 4;283(14):9089-100
10202534 - Annu Rev Neurosci. 1999;22:123-44
11193175 - Ann N Y Acad Sci. 2000;920:42-5
21304957 - PLoS One. 2011;6(1):e16706
24860424 - Front Mol Neurosci. 2014 May 13;7:42
16794039 - Science. 2006 Jul 21;313(5785):324-8
12781588 - Parkinsonism Relat Disord. 2003 Jun;9(5):247-51
25548532 - Exp Neurobiol. 2014 Dec;23(4):324-36
22791686 - Mov Disord. 2013 Jan;28(1):41-50
19409267 - Neuron. 2009 Apr 30;62(2):218-29
12732244 - Neuroscience. 2003;118(4):985-1002
3080808 - Science. 1986 Feb 28;231(4741):987-9
15297935 - Am J Hum Genet. 2004 Oct;75(4):669-77
15980593 - Methods Mol Biol. 2005;299:19-33
9399209 - Mov Disord. 1997 Nov;12(6):871-6
10646524 - J Neurochem. 2000 Feb;74(2):721-9
11701929 - Science. 2001 Nov 9;294(5545):1346-9
15451224 - Lancet. 2004 Sep 25-Oct 1;364(9440):1167-9
11050221 - Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):11869-74
24984882 - J Neurochem. 2014 Dec;131(6):859-67
23427326 - Neurology. 2013 Mar 12;80(11):1062-4
14767717 - J Neural Transm (Vienna). 2004 Feb;111(2):141-57
9538008 - Biochemistry. 1998 Apr 7;37(14):4901-9
12351642 - J Biol Chem. 2002 Dec 13;277(50):48976-83
24851801 - Neurobiol Dis. 2014 Sep;69:134-43
16399671 - J Neurosci. 2006 Jan 4;26(1):41-50
9506559 - Ann Neurol. 1998 Mar;43(3):394-7
25209836 - Acta Neuropathol Commun. 2014;2:132
23363402 - J Neurochem. 2013 Jul;126(1):131-44
24503004 - Ageing Res Rev. 2014 Mar;14:19-30
19957214 - Neurotox Res. 2011 Jan;19(1):63-72
11813001 - Nat Cell Biol. 2002 Feb;4(2):160-4
10707987 - Neuron. 2000 Jan;25(1):239-52
23344955 - J Biol Chem. 2013 Mar 15;288(11):7438-49
10964942 - J Neurosci. 2000 Sep 1;20(17):6365-73
12946053 - J Neural Transm Suppl. 2003;(65):145-55
12145295 - J Biol Chem. 2002 Oct 11;277(41):38884-94
18384642 - J Neurochem. 2008 Jul;106(1):24-36
1510383 - Ann Neurol. 1992;32 Suppl:S69-75
20463956 - PLoS One. 2010;5(5):e10481
22163275 - PLoS One. 2011;6(12):e27959
24043770 - Proc Natl Acad Sci U S A. 2013 Oct 29;110(44):17726-31
24155156 - Neurotox Res. 2014 Jan;25(1):13-23
9278044 - Nature. 1997 Aug 28;388(6645):839-40
11806835 - Genome Biol. 2002;3(1):REVIEWS3002
3086766 - Neuropharmacology. 1986 Apr;25(4):451-4
12719433 - J Biol Chem. 2003 Jul 4;278(27):25009-13
24833599 - Mol Neurobiol. 2014 Oct;50(2):685-701
4978022 - J Neuropathol Exp Neurol. 1969 Jul;28(3):419-41
19429081 - Neurosci Lett. 2009 May 1;454(3):187-92
23028833 - PLoS One. 2012;7(9):e45183
1737070 - Biochim Biophys Acta. 1992 Jan 16;1138(1):6-10
12200193 - Neurotoxicol Teratol. 2002 Sep-Oct;24(5):621-8
12461550 - Nat Rev Neurosci. 2002 Dec;3(12):932-42
21410644 - FEBS J. 2011 May;278(10):1688-98
8113797 - J Neurochem. 1994 Mar;62(3):1097-101
23643800 - Prog Neurobiol. 2013 Jul-Aug;106-107:17-32
10747881 - J Biol Chem. 2000 Jun 16;275(24):18344-9
7605801 - Biochim Biophys Acta. 1995 Jun 9;1271(2-3):343-8
10737635 - J Neurochem. 2000 Apr;74(4):1758-65
21748932 - Acta Neurol Belg. 2011 Jun;111(2):130-5
16000336 - Brain. 2005 Nov;128(Pt 11):2654-64
12893833 - J Biol Chem. 2003 Oct 24;278(43):42225-33
10934145 - Am J Pathol. 2000 Aug;157(2):401-10
22110584 - PLoS One. 2011;6(11):e26159
20887775 - Neurosci Lett. 2010 Dec 17;486(3):235-9
16611810 - J Neurosci. 2006 Apr 12;26(15):3942-50
21723784 - Trends Mol Med. 2011 Sep;17(9):485-93
9756856 - J Biol Chem. 1998 Oct 9;273(41):26292-4
15541018 - Pigment Cell Res. 2004 Dec;17(6):610-7
23967127 - PLoS One. 2013;8(8):e70872
22860226 - ACS Chem Neurosci. 2012 Jul 18;3(7):569-74
16480958 - Biochem Biophys Res Commun. 2006 Mar 31;342(1):330-5
2597314 - J Neural Transm Park Dis Dement Sect. 1989;1(4):279-95
10506125 - J Biol Chem. 1999 Oct 8;274(41):28849-52
19074459 - Hum Mol Genet. 2009 Mar 1;18(5):872-87
22966478 - Parkinsons Dis. 2012;2012:920953
12631585 - FASEB J. 2003 Mar;17(3):500-2
7855075 - Pigment Cell Res. 1994 Aug;7(4):263-73
23934922 - J Parkinsons Dis. 2011;1(2):205-16
24093081 - Am J Neurodegener Dis. 2013 Sep 18;2(3):145-75
14593171 - Science. 2003 Oct 31;302(5646):841
18390556 - J Biol Chem. 2008 Jun 13;283(24):16808-17
16755380 - J Neural Transm (Vienna). 2006 Jun;113(6):757-67
17418429 - Trends Neurosci. 2007 May;30(5):244-50
15717014 - NeuroRx. 2004 Jan;1(1):139-54
19915576 - Nat Genet. 2009 Dec;41(12):1303-7
17055279 - Neurobiol Dis. 2007 Jan;25(1):134-49
15916835 - Neurobiol Aging. 2006 Mar;27(3):506-12
18451726 - J Neuropathol Exp Neurol. 2008 May;67(5):402-16
21461961 - J Neural Transm (Vienna). 2011 Nov;118(11):1575-83
15308292 - Neurosci Lett. 2004 Aug 26;367(1):34-9
12911622 - J Neurochem. 2003 Sep;86(5):1142-8
24936070 - J Biol Chem. 2014 Aug 8;289(32):21856-76
9585251 - Pigment Cell Res. 1998 Apr;11(2):120-6
18502751 - J Biol Chem. 2008 Jul 18;283(29):20288-98
12590943 - Neurochem Int. 2003 Jun;42(7):603-6
22006323 - Proc Natl Acad Sci U S A. 2011 Oct 25;108(43):17797-802
15480837 - J Neural Transm (Vienna). 2004 Oct;111(10-11):1253-65
3411354 - J Neurosci. 1988 Aug;8(8):2804-15
8263538 - J Neurochem. 1994 Jan;62(1):369-71
3264893 - Neurosci Lett. 1988 Oct 31;93(1):1-6
21994367 - J Neurosci. 2011 Oct 12;31(41):14508-20
16567160 - FEBS Lett. 2006 Apr 3;580(8):2147-52
24168368 - CNS Neurol Disord Drug Targets. 2014;13(4):630-7
1919577 - J Neurochem. 1991 Nov;57(5):1609-14
10092675 - J Biol Chem. 1999 Apr 2;274(14):9843-6
21761319 - Methods Mol Biol. 2011;755:363-74
15541309 - Neuron. 2004 Nov 18;44(4):601-7
15087508 - Science. 2004 May 21;304(5674):1158-60
20711177 - Nat Genet. 2010 Sep;42(9):781-5
11425308 - Biochemistry. 2001 Jul 3;40(26):7812-9
25268550 - Biochemistry. 2014 Oct 21;53(41):6419-21
23338671 - J Neural Transm (Vienna). 2013 Apr;120(4):565-9
19701583 - Sheng Li Xue Bao. 2009 Aug 25;61(4):324-30
11958955 - Free Radic Biol Med. 2002 Mar 15;32(6):544-50
15465911 - Proc Natl Acad Sci U S A. 2004 Oct 12;101(41):14966-71
19889641 - J Biol Chem. 2010 Jan 22;285(4):2807-22
5692344 - Neurology. 1968 Aug;18(8):817-20
23938306 - J Parkinsons Dis. 2013;3(1):1-11
14755719 - Ann Neurol. 2004 Feb;55(2):164-73
19525899 - J Neuropathol Exp Neurol. 2009 May;68(5):515-24
16362626 - J Neural Transm (Vienna). 2006 May;113(5):633-44
22938712 - Pigment Cell Melanoma Res. 2012 Nov;25(6):792-803
16298531 - Neurobiol Dis. 2006 Mar;21(3):541-8
12907248 - Biochem Pharmacol. 2003 Aug 1;66(3):489-94
24746362 - Neurobiol Aging. 2014 Sep;35(9):2180.e1-5
18018486 - Neuropathology. 2007 Oct;27(5):494-506
21613474 - J Neurosci. 2011 May 25;31(21):7604-18
12859192 - Biochemistry. 2003 Jul 22;42(28):8465-71
9353954 - Physiol Chem Phys Med NMR. 1997;29(1):15-22
23983262 - Proc Natl Acad Sci U S A. 2013 Oct 8;110(41):E3945-54
12887698 - J Neurochem. 2003 Aug;86(4):1015-23
12835109 - Neurotox Res. 1999 Dec;1(2):141-7
16957086 - J Neurosci. 2006 Sep 6;26(36):9304-11
24252804 - J Parkinsons Dis. 2013;3(4):461-91
20392839 - Mol Biol Cell. 2010 Jun 1;21(11):1850-63
15953825 - Mol Neurobiol. 2005;31(1-3):243-54
12446870 - Science. 2003 Jan 10;299(5604):256-9
16847063 - J Biol Chem. 2006 Oct 6;281(40):29739-52
17108165 - J Neurosci. 2006 Nov 15;26(46):11915-22
23314528 - Rev Neurosci. 2013;24(2):115-23
9197268 - Science. 1997 Jun 27;276(5321):2045-7
17349813 - Parkinsonism Relat Disord. 2007 Aug;13(6):323-32
9750188 - Genome Res. 1998 Sep;8(9):871-80
ref56
ref59
ref58
ref53
ref52
ref55
ref54
Lashuel (ref43) 2005; 299
Poewe (ref4) 2010; 7
Fujiwara (ref57) 2002; 4
ref51
Cabin (ref61) 2002; 22
Li (ref150) 2011; 111
ref46
ref45
ref48
ref47
ref42
ref41
ref44
ref7
ref9
ref3
ref6
ref5
ref100
ref101
ref40
Azeredo da Silveira (ref80) 2009; 18
ref34
ref37
ref36
ref31
ref148
ref30
ref149
ref33
ref146
ref32
Ramanan (ref39) 2013; 18
ref38
ref155
ref156
ref153
ref154
ref151
ref152
ref24
ref23
ref26
Lavedan (ref49) 1998; 8
ref25
ref20
ref159
ref22
ref157
ref21
ref158
Jenner (ref8) 2013; 3
Kahle (ref78) 2000; 20
ref28
ref27
ref29
Zhou (ref103) 2009; 61
Okun (ref110) 1997; 29
ref162
ref160
ref161
ref13
ref12
ref15
ref128
ref14
ref129
Maroteaux (ref50) 1988; 8
ref97
ref126
Zecca (ref147) 2003; 65
ref96
ref127
ref11
ref99
ref124
ref10
ref98
ref125
ref17
ref16
ref19
ref18
Wilms (ref123) 2003; 17
ref93
ref133
ref92
ref134
ref95
ref131
ref94
ref132
ref130
ref91
ref90
ref89
ref139
ref86
ref85
ref138
ref88
ref135
ref87
ref136
Murphy (ref60) 2000; 20
Dias (ref74) 2013; 3
ref82
ref144
ref81
ref145
ref84
ref142
ref83
ref143
ref140
ref141
ref79
ref108
ref109
ref106
ref107
ref75
ref104
ref105
ref77
ref102
Khalaf (ref35) 2014; 289
ref76
ref2
ref1
ref71
ref111
ref70
ref112
ref73
ref72
ref68
ref119
ref67
ref117
ref69
ref118
ref64
ref115
Gründemann (ref137) 2011; 755
ref63
ref116
ref66
ref113
ref65
ref114
ref122
ref62
ref120
ref121
References_xml – ident: ref26
  doi: 10.1016/j.neuron.2009.01.033
– ident: ref41
  doi: 10.1038/42166
– ident: ref133
  doi: 10.1007/s00702-006-0453-2
– ident: ref72
  doi: 10.1523/JNEUROSCI.1560-11.2011
– ident: ref14
  doi: 10.1126/science.1077209
– ident: ref152
  doi: 10.1016/0028-3908(86)90242-X
– ident: ref101
  doi: 10.1385/MN:31:1-3:243
– volume: 3
  start-page: 461
  year: 2013
  ident: ref74
  article-title: The role of oxidative stress in Parkinson’s disease
  publication-title: J. Park. Dis.
  contributor:
    fullname: Dias
– ident: ref130
  doi: 10.1046/j.1471-4159.1994.62010369.x
– ident: ref52
  doi: 10.1186/gb-2001-3-1-reviews3002
– ident: ref143
  doi: 10.1007/s00702-005-0410-5
– ident: ref146
  doi: 10.1371/journal.pone.0045183
– ident: ref19
  doi: 10.1002/ana.410430320
– ident: ref62
  doi: 10.1073/pnas.0406283101
– ident: ref138
  doi: 10.1371/journal.pone.0010481
– ident: ref113
  doi: 10.1111/j.1600-0749.1987.tb00403.x
– ident: ref69
  doi: 10.1126/science.1129462
– ident: ref134
  doi: 10.1046/j.1471-4159.2003.01923.x
– ident: ref131
  doi: 10.1097/00005072-196907000-00005
– volume: 65
  start-page: 145
  year: 2003
  ident: ref147
  article-title: The neuromelanin of human substantia nigra: Structure, synthesis and molecular behaviour
  publication-title: J. Neural Transm. Suppl.
  doi: 10.1007/978-3-7091-0643-3_8
  contributor:
    fullname: Zecca
– ident: ref160
  doi: 10.1074/jbc.M205518200
– ident: ref7
  doi: 10.1007/s00702-013-0966-4
– ident: ref66
  doi: 10.1016/j.neulet.2009.02.056
– ident: ref151
  doi: 10.1016/j.bbapap.2013.03.008
– ident: ref94
  doi: 10.1074/jbc.274.41.28849
– ident: ref12
  doi: 10.1016/j.molmed.2011.05.003
– volume: 111
  start-page: 130
  year: 2011
  ident: ref150
  article-title: α-Synuclein functions as a negative regulator for expression of tyrosine hudroxylase
  publication-title: Acta Neurol. Belg.
  contributor:
    fullname: Li
– ident: ref11
  doi: 10.1016/j.neuron.2004.11.005
– ident: ref87
  doi: 10.1073/pnas.1309991110
– ident: ref114
  doi: 10.1046/j.1471-4159.1994.62031097.x
– ident: ref149
  doi: 10.1074/jbc.M709014200
– ident: ref23
  doi: 10.1016/j.neurobiolaging.2014.03.024
– ident: ref162
  doi: 10.1021/cn300034t
– ident: ref5
  doi: 10.1002/mds.870120607
– ident: ref132
  doi: 10.1002/ana.410320712
– ident: ref159
  doi: 10.1038/nrn983
– ident: ref153
  doi: 10.1002/cne.20098
– ident: ref155
  doi: 10.1016/S0896-6273(00)80886-7
– volume: 3
  start-page: 1
  year: 2013
  ident: ref8
  article-title: Parkinson’s disease—The debate on the clinical phenomenology, aetiology, pathology and pathogenesis
  publication-title: J. Parkinsons Dis.
  doi: 10.3233/JPD-130175
  contributor:
    fullname: Jenner
– ident: ref59
  doi: 10.1021/bi972776r
– ident: ref95
  doi: 10.1016/j.baga.2011.01.007
– ident: ref83
  doi: 10.1097/NEN.0b013e3186fc995
– ident: ref100
  doi: 10.1016/j.febslet.2006.03.018
– ident: ref136
  doi: 10.1111/j.1471-4159.1991.tb06358.x
– ident: ref10
  doi: 10.1126/science.1090278
– ident: ref56
  doi: 10.1126/science.1063522
– ident: ref76
  doi: 10.1186/s40478-014-0132-8
– ident: ref79
  doi: 10.1074/jbc.M213217200
– ident: ref106
  doi: 10.1097/00005072-196507000-00003
– volume: 29
  start-page: 15
  year: 1997
  ident: ref110
  article-title: The role of peroxidase in neuromelanin synthesis: A review
  publication-title: Physiol. Chem. Phys. Med. NMR
  contributor:
    fullname: Okun
– ident: ref42
  doi: 10.1074/jbc.M710560200
– ident: ref115
  doi: 10.1007/BF02263482
– ident: ref68
  doi: 10.1074/jbc.M110.213538
– ident: ref157
  doi: 10.1371/journal.pone.0027959
– ident: ref135
  doi: 10.1016/S0006-2952(03)00293-4
– ident: ref47
  doi: 10.1074/jbc.M208192200
– ident: ref44
  doi: 10.1074/jbc.M409946200
– ident: ref102
  doi: 10.1016/S0306-4522(03)00036-8
– ident: ref15
  doi: 10.1126/science.1096284
– ident: ref117
  doi: 10.1007/s00702-004-0211-2
– ident: ref73
  doi: 10.1021/bi0102398
– ident: ref91
  doi: 10.1074/jbc.M000206200
– ident: ref24
  doi: 10.1016/j.arr.2014.01.004
– ident: ref48
  doi: 10.1016/j.nbd.2014.05.009
– volume: 22
  start-page: 8797
  year: 2002
  ident: ref61
  article-title: Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.22-20-08797.2002
  contributor:
    fullname: Cabin
– ident: ref140
  doi: 10.1016/j.neurobiolaging.2005.02.015
– ident: ref86
  doi: 10.3389/fnmol.2014.00042
– ident: ref111
  doi: 10.1073/pnas.97.22.11869
– ident: ref118
  doi: 10.1016/0925-4439(95)00058-C
– ident: ref71
  doi: 10.1091/mbc.E09-09-0801
– ident: ref81
  doi: 10.1097/NEN.0b013e3181a24b53
– ident: ref84
  doi: 10.1074/jbc.M109.081950
– ident: ref53
  doi: 10.1038/nature10324
– volume: 8
  start-page: 871
  year: 1998
  ident: ref49
  article-title: The synuclein family
  publication-title: Genome Res.
  doi: 10.1101/gr.8.9.871
  contributor:
    fullname: Lavedan
– ident: ref88
  doi: 10.2174/18715273113126660195
– ident: ref158
  doi: 10.1371/journal.pone.0070872
– ident: ref46
  doi: 10.1111/jnc.12175
– ident: ref139
  doi: 10.1016/S0197-0186(02)00161-4
– ident: ref119
  doi: 10.1046/j.1471-4159.2003.01917.x
– ident: ref3
  doi: 10.1602/neurorx.1.1.139
– ident: ref70
  doi: 10.1073/pnas.0710685105
– ident: ref112
  doi: 10.1126/science.3080808
– ident: ref30
  doi: 10.1007/s12640-009-9140-z
– ident: ref33
  doi: 10.1016/S0306-4522(00)00077-4
– volume: 299
  start-page: 19
  year: 2005
  ident: ref43
  article-title: In vitro preparation of prefibrillar intermediates of amyloid-beta and alpha-synuclein
  publication-title: Methods Mol. Biol.
  contributor:
    fullname: Lashuel
– ident: ref77
  doi: 10.1074/jbc.M600933200
– ident: ref122
  doi: 10.1007/s12035-013-8586-4
– volume: 755
  start-page: 363
  year: 2011
  ident: ref137
  article-title: UV-laser microdissection and mRNA expression analysis of individual neurons from postmortem Parkinson’s disease brains
  publication-title: Methods Mol. Biol.
  doi: 10.1007/978-1-61779-163-5_30
  contributor:
    fullname: Gründemann
– ident: ref36
  doi: 10.1111/jnc.12806
– ident: ref92
  doi: 10.1046/j.1471-4159.2000.740721.x
– ident: ref116
  doi: 10.1007/BF03033277
– ident: ref34
  doi: 10.1074/jbc.274.14.9843
– volume: 8
  start-page: 2804
  year: 1988
  ident: ref50
  article-title: Synuclein: A neuron-specific protein localized to the nucleus and presynaptic nerve terminal
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.08-08-02804.1988
  contributor:
    fullname: Maroteaux
– ident: ref51
  doi: 10.1016/j.neuron.2013.09.004
– volume: 7
  start-page: 229
  year: 2010
  ident: ref4
  article-title: Levodopa in the treatment of Parkinson’s disease: An old drug still going strong
  publication-title: Clin. Interv. Aging
  contributor:
    fullname: Poewe
– ident: ref13
  doi: 10.1016/S1353-8020(03)00016-6
– ident: ref120
  doi: 10.1111/j.1600-0749.1998.tb00721.x
– ident: ref125
  doi: 10.1007/s00702-003-0080-0
– ident: ref63
  doi: 10.1074/jbc.M112.439497
– ident: ref89
  doi: 10.1073/pnas.1315654110
– ident: ref17
  doi: 10.1086/424492
– ident: ref108
  doi: 10.1111/j.1600-0749.1994.tb00061.x
– ident: ref154
  doi: 10.1016/j.neulet.2004.05.118
– ident: ref124
  doi: 10.1007/s12640-013-9435-y
– ident: ref1
  doi: 10.1146/annurev.neuro.22.1.123
– ident: ref25
  doi: 10.1016/j.pneurobio.2013.04.004
– ident: ref98
  doi: 10.1016/j.bbrc.2006.01.148
– ident: ref99
  doi: 10.1016/j.brainres.2013.01.024
– ident: ref37
  doi: 10.1021/bi5010365
– ident: ref40
  doi: 10.1038/ng.485
– ident: ref127
  doi: 10.1111/j.1600-0749.2004.00201.x
– ident: ref145
  doi: 10.1074/jbc.M300227200
– ident: ref128
  doi: 10.1016/0925-4439(92)90144-C
– volume: 20
  start-page: 3214
  year: 2000
  ident: ref60
  article-title: Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.20-09-03214.2000
  contributor:
    fullname: Murphy
– ident: ref28
  doi: 10.1111/j.1471-4159.2008.05385.x
– ident: ref55
  doi: 10.1111/j.1749-6632.2000.tb06903.x
– volume: 289
  start-page: 21856
  year: 2014
  ident: ref35
  article-title: The H50Q mutation enhances α-synuclein aggregation, secretion and toxicity
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M114.553297
  contributor:
    fullname: Khalaf
– ident: ref105
  doi: 10.1016/j.nbd.2005.08.018
– ident: ref121
  doi: 10.1093/brain/awh584
– ident: ref65
  doi: 10.1074/jbc.M710012200
– ident: ref104
  doi: 10.1371/journal.pone.0016706
– ident: ref18
  doi: 10.1074/jbc.273.41.26292
– ident: ref64
  doi: 10.1523/JNEUROSCI.4308-05.2006
– ident: ref97
  doi: 10.1021/bi0341152
– volume: 4
  start-page: 160
  year: 2002
  ident: ref57
  article-title: α-Synuclein is phosphorylated in synucleinopathy lesions
  publication-title: Nat. Cell Biol.
  doi: 10.1038/ncb748
  contributor:
    fullname: Fujiwara
– ident: ref96
  doi: 10.1016/S0891-5849(02)00741-4
– ident: ref45
  doi: 10.1111/j.1440-1789.2007.00803.x
– volume: 61
  start-page: 324
  year: 2009
  ident: ref103
  article-title: Dual effects of different concentrations of alpha-synuclein on the neurotoxicity of 6-hydroxydopamine in SH-SY5Y cells
  publication-title: Sheng Li Xue Bao
  contributor:
    fullname: Zhou
– ident: ref67
  doi: 10.1016/j.neulet.2010.09.061
– volume: 20
  start-page: 6365
  year: 2000
  ident: ref78
  article-title: Subcellular localization of wild-type and Parkinson’s disease-associated mutant alpha-synuclein in human and transgenic mouse brain
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.20-17-06365.2000
  contributor:
    fullname: Kahle
– ident: ref93
  doi: 10.1016/S0002-9440(10)64553-1
– ident: ref148
  doi: 10.1111/pcmr.12014
– ident: ref38
  doi: 10.1007/s12035-014-8738-1
– ident: ref16
  doi: 10.1038/ng.642
– ident: ref27
  doi: 10.1155/2012/920953
– ident: ref75
  doi: 10.5607/en.2014.23.4.324
– ident: ref129
  doi: 10.1046/j.1471-4159.2000.0741758.x
– ident: ref161
  doi: 10.1523/JNEUROSCI.0519-06.2006
– ident: ref141
  doi: 10.1016/j.nbd.2006.08.021
– ident: ref22
  doi: 10.1007/s00401-013-1096-7
– ident: ref32
  doi: 10.1371/journal.pone.0026159
– ident: ref54
  doi: 10.1073/pnas.1113260108
– ident: ref142
  doi: 10.1016/S0892-0362(02)00218-0
– ident: ref31
  doi: 10.1016/S0140-6736(04)17103-1
– ident: ref58
  doi: 10.1111/j.1742-4658.2011.08093.x
– ident: ref6
  doi: 10.1016/j.parkreldis.2006.12.014
– ident: ref2
  doi: 10.1002/mds.25095
– ident: ref90
  doi: 10.1523/JNEUROSCI.4965-05.2006
– ident: ref107
  doi: 10.1212/WNL.18.8.817
– ident: ref126
  doi: 10.1016/0304-3940(88)90002-X
– ident: ref85
  doi: 10.1523/JNEUROSCI.0297-11.2011
– ident: ref156
  doi: 10.1523/JNEUROSCI.3821-06.2006
– ident: ref9
  doi: 10.1126/science.276.5321.2045
– ident: ref21
  doi: 10.1212/WNL.0b013e31828727ba
– ident: ref144
  doi: 10.1016/j.tins.2007.03.009
– ident: ref20
  doi: 10.1002/ana.10795
– volume: 17
  start-page: 500
  year: 2003
  ident: ref123
  article-title: Activation of microglia by human neuromelanin is NF-kappaB dependent and involves p38 mitogen-activated protein kinase: Implications for Parkinson’s disease
  publication-title: FASEB J.
  doi: 10.1096/fj.02-0314fje
  contributor:
    fullname: Wilms
– ident: ref29
  doi: 10.1007/s00702-011-0636-3
– volume: 18
  start-page: 872
  year: 2009
  ident: ref80
  article-title: Phosphorylation does not prompt, nor prevent, the formation of α-synuclein toxic species in a rat model of Parkinson’s disease
  publication-title: Hum. Mol. Genet.
  contributor:
    fullname: Azeredo da Silveira
– volume: 18
  start-page: 145
  year: 2013
  ident: ref39
  article-title: Pathways to neurodegeneration: Mechanistic insights from GWAS in Alzheimer’s disease, Parkinson’s disease, and related disorders
  publication-title: Am. J. Neurodegener. Dis.
  contributor:
    fullname: Ramanan
– ident: ref82
  doi: 10.1515/revneuro-2012-0071
– ident: ref109
  doi: 10.1046/j.1471-4159.1997.69041720.x
SSID ssj0000800823
Score 2.193151
SecondaryResourceType review_article
Snippet Parkinson's disease (PD) is a very common neurodegenerative disorder characterized by the accumulation of α-synuclein (α-syn) into Lewy body (LB) inclusions...
Parkinson’s disease (PD) is a very common neurodegenerative disorder characterized by the accumulation of α-synuclein (α-syn) into Lewy body (LB) inclusions...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 1122
SubjectTerms alpha-synuclein
alpha-Synuclein - genetics
alpha-Synuclein - metabolism
Animals
Humans
Melanins - metabolism
neuromelanin
Oxidative Stress
Parkinson Disease - metabolism
Parkinson Disease - pathology
Parkinson's disease
Protein Aggregation, Pathological - metabolism
Review
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV27TsMwFLVQJxYElEegICMhtqhJbKf2WB5VhVQWqNQt8quiiBpE26Ebv8Hv8SVcO6FKERILUiYng3NPnHtOcs81Quc6UdQCjY7HHWZjaoiOlbQk9r0_uNbCcOHdyIO7vD-ktyM2qm315WvCyvbAZeDaVjKubE68aZICuRKJIswyZjRwDUPH4e2bZDUx9VTxIJ6R0pBHQNe3vZudQUJLs2wtBYVO_b_Ry59VkrW009tGWxVfxN1ynjtow7pd1Ow60MrTJb7AoYIzfBpvokH4vFc6FXBVgIVD942pfZZu4rB0Bne9uza-XzrfyRjG4PDW5-AC-3z_mOHr8p_NHhr2bh6u-nG1XUKsaYfNY8OJJUaKRFtKBVc609K7AYkEikRNJozk1hCIGRvDWEKMScUYMpjKDEBiyD5quBdnDxE2knRA6mSAFmS5HFQV44kVVqZUUSV4BCBXESxey64YBagJH-iiFugIXfrori7xrazDAABcVAAXfwEcodY3NkW1vmZFmoPyCvI6Qmer07Ay_O8O6ezLIlyT5r5yMo3QQQnlaiZexUEayCPUWQN5barrZ9zkMXTfhtjmoOyP_uPejtEmEDAWSs9YCzXmbwt7AiRnrk7D8_wFb8D88A
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NT9wwEB3R5dKeCrQ0hSIjofZkkcR2Yp8QbUGIqlxapL1F_lqKVLyUXQ7775lxwpatKqScHB9GM7bnzXjeGODAl05GhNF80qrIZRCeOxsFp94f2nsTtCE28veL5uxSno_VeEi4zYayysczMR_UYeopR35YNYi1c0B1dPuH06tRdLs6PKHxAtarGl05rud23C5zLISGdC16Wp7A6P6QOO0K3VpV1yuOKPfr_x_I_LdW8onzOX0Nr4iQwPos_gasxbQJW8cJo-WbBfvIcg1nTo5vwbec4Ou5CmwowWK5_8ZN_G3TdWI2BXZM_Fr-Y5GolzGO4Ufk58wD-zRjX_s7mzdweXry88sZH55L4F62as6DFlEEa0ofpTTa-dpbYgMKixBJhtoEq2MQQU7UBMdKEUJlJujBXB3QJEG8hVGapvgOWLCixVCnRmuhl2swqlK6jCbaSjrpjC7QyIPuutu-K0aH0QSpuHui4gI-k16XU6iVdR6Y3l11w87oolXaxUYQK1YiejalEyoqFTyCSRS2gN1Hq3TD_pp1f1dDAfvL37gz6LrDpji9z3OqhionqwK2eyMuJaEoDt1AU0C7Yt4VUVf_pOtfufs26rbByP7982LtwEuEVioXlaldGM3v7uMHhC9zt5fX6APLYfEq
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9wwEB4heuml4tFHeMmVqt7SJrGdtQ8ILW0RqrS9tCtxi_zaAgIvLIvE3vgb_D1-SWec7IpFHCvlZCeSM2Nnvs-ZbwzwyRVWBITR-agnQy48d7k1gedU-0M5p73SpEYe_KqPh-LniTxZgflhnJ0Bb16kdnSe1HBy8eXuenaAC36fGCdS9q8kVJcYq8oKv8WvKgyJlNs16HD-eQeLVMVbfd7zZ5YiUirc_xLafJ40-SQKHa3Bmw4-sn7r73VYCXEDNvsRqfPljH1mKaEz7ZRvwiDt9rXCBdblY7FUjOMyXJh4FpmJnvVJbJv_nkUqbIxteJESOonCHu8fbtj39hfOWxge_fjz7TjvTk_InejJae4VD9wbXbgghFbWVc6QOJAbREzCV9obFTz3YiRH2FZw70s9woBmK48e8vwdrMZxDB-AecN7yHwqdB4GvRpJllRF0MGUwgqrVYY-7yzYXLVFMhokF2To5omhMzgk6y5uocrWqWE8-dt0C6UJRiobak4iWYFgWheWyyCld4gtcbAZ7Mx908xnS1PWSMQS287g46IbFwr9_TAxjG_TPWVNiZRlBu9bVy5GQqQOo0KdQW_JyUtDXe6JZ6epGDfatkaiv_U_3m0bXiMekykTTe7A6nRyG3YR80ztXprP_wBZsQQH
  priority: 102
  providerName: Scholars Portal
Title Interaction between Neuromelanin and Alpha-Synuclein in Parkinson's Disease
URI https://www.ncbi.nlm.nih.gov/pubmed/26057626
https://www.proquest.com/docview/1696013383
https://search.proquest.com/docview/1691600941
https://pubmed.ncbi.nlm.nih.gov/PMC4496713
https://doaj.org/article/ea58be630579481d90b35e55dc540d4f
Volume 5
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT9tAEB0BvXBBFCiY0mgrVdxMbO-uvXsMFIQqBSEoUm7WfgWCkg2CcODWv9G_11_S2bUTJainSpYPa1tazYw97-3OGwN8M5lmDmF0Oqy4S5mlJtXK0TT0_hDGSCtkUCP3r8rLO_ZjwAdrwOdamFi0b_ToxI8nJ370EGsrnyamO68T6173zxiTJZKr7jqsY_pdouiPLQQSBW20eBQpfTcI2TnmsrwI_64JAB6_AOVKIor9-v8FMt_XSi4ln4tt2GpRI-k1s_sIa87vwG7PI2OevJFjEus44wL5LvTjIl-jVyBtGRaJPTgmbqz8yBPlLekFjW16--ZDP2McwyMIoKMW7M-v3y_ke7Nzswd3F-c_zy7T9qcJqWEVn6VWUEetkplxaCahTWFU0ARShUCJ2UJaJZyllg35EMcyam0uh5jHdGHRMZZ-gg0_9e4AiFW0QsJToM8w15XIrbjInHQqZ5ppKRJ0dWvB-qnpjVEjpwg2r5dsnsBpsO7iltDQOg5Mn-_r1q21U1xoV9KgjWWIoWWmKXecW4OQEiebwNHcN3X7lr3UeYn8K5LsBL4uLuP7ETY9lHfT13hPXob6yTyB_caVi5nMQyGBasXJK1NdvYIhGXtwtyF4-N9PfoZNxF48Vp3xI9iYPb-6L4hvZrqDUT2oOvDh9Pzq-qYTVwnw3GeiEyP9Lyx7Ag0
link.rule.ids 230,313,314,727,780,784,792,864,885,2102,2221,12056,21388,24318,27922,27924,27925,31719,31720,33744,33745,43310,43805,53791,53793,73745,74302
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fTxQxEJ7o8aA8ofhjEbQmRp8adrftXvtEQCGnwMUoJLxtum1PSaSH3PHAf89Mt5ycMSb71O3DZKbtfDOdbwrwzpWdDAij-WSoApdeON7ZIDj1_tDOGa8NsZGPx83oVH45U2c54TbLZZV3Z2I6qP3UUY58u2oQa6eAaufyN6dXo-h2NT-h8RBWqHO6GsDK3v7467dFloXwkK5FT8wTGN9vE6tdoWOr6nrJFaWO_f-CmX9XS95zPwdrsEqUBNbn8Z_AgxCfwvpuxHj54oa9Z6mKM6XH1-Ewpfh6tgLLRVgsdeC4CL9sPI_MRs92iWHLv99E6maMY_gR_TkxwT7M2Kf-1uYZnB7sn3wc8fxgAndyqObcaxGEt6Z0QUqjO1c7S3xAYREkSV8bb3XwwsuJmuBYKbyvzAR9WFd7NIoXz2EQpzG8BOatGGKwU6O90M81GFcpXQYTbCU72RldoJmz7trLvi9Gi_EEqbi9p-IC9kiviynUzDoNTK9-tHlvtMEq3YVGEC9WIn42ZSdUUMo7hJMobAGbd1Zp8w6btX_WQwFvF79xb9CFh41hep3mVA3VTlYFvOiNuJCE4jh0BE0BwyXzLom6_Cee_0z9t1G3Dcb2G_8X6w08Gp0cH7VHn8eHr-AxAi2VSszUJgzmV9dhC8HMvHudV-wtY7v1gA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Rb9QwDLbgJiF4AgasMCBICJ6ia5uklzyhje00GJwmYNLeqjRJYRLLjd3tYf8eO82OHUJIfUrzYNlJ_Nnx5wC8dmUnA8Jo3k9U4NILxzsbBKfeH9o547UhNvLnWXNwLD-eqJNc_7TIZZXXZ2I6qP3cUY58XDWItVNANe5zWcTR3vTd-S9OL0jRTWt-TuM2bKBXLOsRbOzuz46-rDIuhI10LQaSnsBYf0wMd4VOrqrrNbeUuvf_C3L-XTl5wxVN78M9oiewIaf_AG6F-BA2dyLGzmdX7A1LFZ0pVb4JhyndNzAXWC7IYqkbx1n4aeNpZDZ6tkNsW_71KlJnYxzDj6jQiRX2dsH2hhucR3A83f_2_oDnxxO4kxO15F6LILw1pQtSGt252lniBgqLgEn62nirgxde9qrHsVJ4X5ke_VlXezSQF49hFOcxbAHzVkww8KnRdujzGoyxlC6DCbaSneyMLtDkWXft-dAjo8XYglTc3lBxAbuk19UUamydBuYX39u8T9pgle5CI4gjKxFLm7ITKijlHUJLFLaA7WurtHm3Ldo_a6OAV6vfuE_o8sPGML9Mc6qG6iirAp4MRlxJQjEdOoWmgMmaeddEXf8TT3-kXtyo2wbj_Kf_F-sl3MHF2n76MDt8BncRc6lUbaa2YbS8uAzPEdcsuxd5wf4Gqrz5rQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Interaction+between+Neuromelanin+and+Alpha-Synuclein+in+Parkinson%27s+Disease&rft.jtitle=Biomolecules+%28Basel%2C+Switzerland%29&rft.au=Xu%2C+Shengli&rft.au=Chan%2C+Piu&rft.date=2015-06-05&rft.pub=MDPI+AG&rft.eissn=2218-273X&rft.volume=5&rft.issue=2&rft.spage=1122&rft_id=info:doi/10.3390%2Fbiom5021122&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=3742402121
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2218-273X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2218-273X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2218-273X&client=summon